Grove Bank & Trust’s Lifestance Health LFST Stock Holding History

Grove Bank & Trust’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25.1K	Hold	2,342	–	–	﹤0.01%	530
2026 Q1	$14.9K	Buy	2,342 +1,608	+219%	+$11.2K	﹤0.01%	576
2025 Q4	$5.17K	Buy	+734	New	+$4.43K	﹤0.01%	721

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Grove Bank & Trust's LFST Position: Q2 2026 in Review

Grove Bank & Trust held its Lifestance Health (LFST) position steady in Q2 2026 at 2,342 shares worth $25.1K. The position accounts for ﹤0.01% of the portfolio, ranked #530.

Grove Bank & Trust first reported a position in LFST in Q4 2025 and has held it in 3 quarters since. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

Grove Bank & Trust held 2,342 shares of Lifestance Health worth $25.1K as of Q2 2026.
Grove Bank & Trust left its Lifestance Health share count unchanged in Q2 2026.
Lifestance Health made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #530 holding.
Grove Bank & Trust first reported a position in Lifestance Health in Q4 2025 and has held it in 3 quarters since.
287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.